Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Enzolytics Inc. (ENZC)
OTHER OTC:ENZC
Enzolytics (ENZC) Stock Price & Analysis
407 Followers
ENZC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $0.13
Previous Close$0.05
Volume18.47M
Average Volume (3M)11.55M
Market Cap
$149.78M
Enterprise Value$149.92M
Total Cash (Recent Filing)$7.90K
Total Debt (Recent Filing)$141.15K
Price to Earnings (P/E)-52.2
Beta-0.15
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2012Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,438,670,097
10 Day Avg. Volume24,476,883
30 Day Avg. Volume11,549,471
Standard Deviation1.50
R-Squared0.00
Alpha0.34
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.25K
Enterprise Value/Gross Profit4.06K
Enterprise Value/Ebitda-23.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ENZC FAQ
What was Enzolytics Inc.’s price range in the past 12 months?
Enzolytics Inc. lowest stock price was $0.02 and its highest was $0.13 in the past 12 months.
What is Enzolytics Inc.’s market cap?
Currently, no data Available
When is Enzolytics Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Enzolytics Inc.’s earnings last quarter?
Currently, no data Available
Is Enzolytics Inc. overvalued?
According to Wall Street analysts Enzolytics Inc.’s price is currently Overvalued.
Does Enzolytics Inc. pay dividends?
Enzolytics Inc. pays a Notavailable dividend of $156.25 which represents an annual dividend yield of N/A. See more information on Enzolytics Inc. dividends here
What is Enzolytics Inc.’s EPS estimate?
Enzolytics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzolytics Inc. have?
Enzolytics Inc. has 2,880,436,000 shares outstanding.
What happened to Enzolytics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Enzolytics Inc.?
Currently, no hedge funds are holding shares in ENZC
---
Enzolytics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-22.95%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-40.60%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Enzolytics Inc.
Enzolytics, Inc. is a development stage company, which engages in the research and development on the operations and treatment of HIV/Aids virus. It focuses on the commercialization of the license rights of the IPF for the treatment of Aids and Hepatitis C as well as potential other treatments for life threatening diseases. The company was founded on July 28, 2004 and is headquartered in Monrovia, CA.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
Larimar Therapeutics
―
Icosavax
―
Ovid Therapeutics
―
X4 Pharmaceuticals
―
KalVista Pharmaceuticals
―
---